BioCentury
ARTICLE | Clinical News

Ibex preclinical data

September 21, 1998 7:00 AM UTC

IBT published in Thrombosis Research a comparison of Neutralase with protamine, which is marketed to reverse the effects of heparin, in an animal model of venous thrombosis. Neutralase and protamine were equally effective at reversing the anticoagulant activity of heparin. At all doses, Neutralase also protected animals against induction of large clots (thrombi). ...